These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7219025)

  • 1. Evaluation of a sensitive grading system for assessing acute and subchronic delayed neurotoxicity in hens.
    Sprague GL; Sandvik LL; Bickford AA; Castles TR
    Life Sci; 1980 Dec 22-29; 27(25-26):2523-8. PubMed ID: 7219025
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotoxicity of organophosphates. Effects of trio-o-tolyl phosphate in chick ganglia cell cultures.
    Watanabe PG; Sharma RP
    J Comp Pathol; 1975 Jul; 85(3):373-81. PubMed ID: 1170217
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the functional effects of dyflos, tri-o-cresyl phosphate and tri-p-ethylphenyl phosphate in chickens.
    CAVANAGH JB; DAVIES DR; HOLLAND P; LANCASTER M
    Br J Pharmacol Chemother; 1961 Aug; 17(1):21-7. PubMed ID: 13691738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum corticosterone levels in triorthotolyl phosphate-treated chickens.
    Foil L; Satterlee D; Jacobs-Perry L
    Bull Environ Contam Toxicol; 1985 Jun; 34(6):780-6. PubMed ID: 4016286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitory activities of tri-ortho-cresyl phosphate (TOCP) against cholinesterase and neurotoxic esterase].
    Kawai M; Iyatomi A; Kaneko Y
    Sangyo Igaku; 1984 Jan; 26(1):68-9. PubMed ID: 6482069
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of avian muscarinic cholinergic high affinity binding sites by a neurotoxic organophosphate.
    Ali SF; Abou-Donia MB; Bondy SC
    Neurochem Pathol; 1984-1985 Winter; 2(4):267-75. PubMed ID: 6537470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in in vitro brain and spinal cord protein phosphorylation after a single oral administration of tri-o-cresyl phosphate to hens.
    Patton SE; Lapadula DM; O'Callaghan JP; Miller DB; Abou-Donia MB
    J Neurochem; 1985 Nov; 45(5):1567-77. PubMed ID: 4045464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the cholinesterase of the central nervous system by organophosphorus compounds.
    DAVISON AN
    Biochem J; 1953 Jun; 54(3):xix-xx. PubMed ID: 13058939
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphatic tissue response in chickens treated with tri-o-tolyl phosphate.
    Wantanabe PG; Sharma RP
    J Toxicol Environ Health; 1976 May; 1(5):777-86. PubMed ID: 1271485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro degradation of atracurium.
    Cook DR; Stiller R; Ingram M
    Anesth Analg; 1986 May; 65(5):543. PubMed ID: 3754397
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of background neurologic lesions in acute delayed neurotoxicity studies: a comparison o neurohistopathologic lesions induced in commercial hens by tri-o-tolyl phosphate (TOCP) with those observed in negative control hens.
    Bickford AA; Sprague GL
    Neurotoxicology; 1983; 4(2):283-309. PubMed ID: 6685268
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute delayed neurotoxicity in hens dosed with tri-ortho-cresyl phosphate (TOCP): correlation between clinical ataxia and neuropathological findings.
    Prentice DE; Roberts NL
    Neurotoxicology; 1983; 4(2):271-6. PubMed ID: 6685266
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of tri-O-cresyl phosphate-induced delayed neurotoxicity to enhancement of in vitro phosphorylation of hen brain and spinal cord proteins.
    Patton SE; Lapadula DM; Abou-Donia MB
    J Pharmacol Exp Ther; 1986 Nov; 239(2):597-605. PubMed ID: 3772811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, acute delayed and subchronic neurotoxicity studies in the hen: measurements and evaluations of clinical signs following administration of TOCP.
    Roberts NL; Fairley C; Phillips C
    Neurotoxicology; 1983; 4(2):263-70. PubMed ID: 6685265
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptosomal adenosine triphosphatase (ATPase) inhibition by organophosphates.
    Brown HR; Sharma RP
    Experientia; 1976 Dec; 32(12):1540-2. PubMed ID: 139320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triorthotolyl phosphate inhibition of carboxylesterases and potentiation of procaine toxicity.
    Cohen SD; Orzech D
    Biochem Pharmacol; 1977 Oct; 26(19):1791-5. PubMed ID: 907716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Data on the characteristics of the skin resorptive action of tricresyl phosphate in a mixture with adipic acid ether].
    Litau VG
    Gig Tr Prof Zabol; 1975 Sep; (9):58-9. PubMed ID: 1176025
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium and calmodulin-enhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single oral dose of tri-o-cresyl phosphate.
    Suwita E; Lapadula DM; Abou-Donia MB
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6174-8. PubMed ID: 3090552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of acrylate ester toxicity by prior treatment with the carboxylesterase inhibitor triorthotolyl phosphate (TOTP).
    Silver EH; Murphy SD
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):208-19. PubMed ID: 7222037
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinesterase and carboxylesterase inhibition by dichlorvos and interactions with malathion and triorthotolyl phosphate.
    Cohen SD; Ehrich M
    Toxicol Appl Pharmacol; 1976 Jul; 37(1):39-48. PubMed ID: 968905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.